Micropore Closure Kinetics at Various Body Sites

Inclusion Criteria: * 18 - 50 years of age * Healthy, non-obese men and women * Identify as African American or Black, Asian, Hispanic or Latino, Caucasian/White, bi-/multiracial or other Exclusion Criteria: * Unable to give consent * Severe general allergies requiring chronic treatment with steroids or antihistamines * Previous adverse reaction to micropatch application * Previous history of keloids * Known allergy or adverse reaction to medical tape/adhesive or aloe vera * Any inflammatory diseases of the skin; psoriasis, atopic dermatitis, and blistering skin disorders * Diseases associated with altered immune function (including but not limited to: rheumatoid arthritis, diabetes, lupus, HIV/AIDS) * Any subjects taking medication that impairs the immune system (including but not limited to corticosteroids, TNF inhibitors, monoclonal antibodies, chemotherapy agents) * Any current malignancy or history of malignancy present at the micropatch application sites * Eczema or scaling present at the application sites * Any current inflammation or irritation present at the application sites (including but not limited to: rash, inflammation, erythema, edema, blisters) * BMI\>29.9 * Uncontrolled mental illness that would, in the opinion of the physician, affect the subject's ability to understand or reliably participate in the study * Subjects taking medications in the following therapeutic classes will be excluded: HMGCoA reductase inhibitors ("statins"), oral or topical steroids…